Selective JAK1 Inhibition Using Upadacitinib for the Management of Inflammatory Bowel Diseases: The Powerful Pill. Can IBD Today 2023, 1 (S11), 2–11. https://doi.org/10.58931/cibdt.2023.1S1121.